Lawlor, AilbheLin, CarolGómez Rivas, JuanIbáñez, LauraAbad López, PabloWillemse, Peter-Paul M.Omar, Muhammad ImranRemmers, SebastiaanCornford, PhilipRajwa, PawelNicoletti, RossellaGandaglia, GiorgioTeoh, Jeremy Yuen-ChunMoreno Sierra, JesúsGolozar, AsiehBjartell, AndersEvans-Axelsson, SusanN'Dow, JamesZong, JihongRibal, Maria JoseRoobol, Monique JVan Hemelrijck, MiekeBeyer, KatharinaPIONEER Consortium2024-06-172024-06-172024-05-01Lawlor, A, Lin, C, Gómez Rivas, J, Ibáñez, L, Abad López, P, Willemse, P-P M, Omar, M I, Remmers, S, Cornford, P, Rajwa, P, Nicoletti, R, Gandaglia, G, Teoh, J Y-C, Moreno Sierra, J, Golozar, A, Bjartell, A, Evans-Axelsson, S, N'Dow, J, Zong, J, Ribal, M J, Roobol, M J, Van Hemelrijck, M, Beyer, K & PIONEER Consortium 2024, 'Predictive Models for Assessing Patients’ Response to Treatment in Metastatic Prostate Cancer : A Systematic Review ', European Urology Open Science, vol. 63, pp. 126-135. https://doi.org/10.1016/j.euros.2024.03.0122666-1683ORCID: /0000-0002-1597-3126/work/161797070ORCID: /0000-0001-5340-0081/work/162725428https://hdl.handle.net/2164/2362510787778engSDG 3 - Good Health and Well-beingadverse eventsdisease progressionmetastatic prostate canceroverall survivalpredictive modelstreatment discontinuationTreatment selectionToxicityR MedicineEuropean Commission777492Supplementary Datahttps://doi.org/10.1016/j.euros.2024.03.012RJournal article10.1016/j.euros.2024.03.01263